Article info
PDFImage of the moment
Spinal cord tumour misdiagnosed as seropositive neuromyelitis optica spectrum disorder
- Correspondence to Dr Romain Deschamps, Department of Neurology, Fondation Ophtalmologique Adolphe de Rothschild, 25 Rue Manin, Paris 75019, France; rdeschamps{at}fo-rothschild.fr
Citation
Spinal cord tumour misdiagnosed as seropositive neuromyelitis optica spectrum disorder
Publication history
- Accepted December 14, 2014
- First published January 20, 2015.
Online issue publication
April 14, 2016
Article Versions
- Previous version (14 April 2016).
- You are viewing the most recent version of this article.
Request permissions
If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.
Copyright information
Published by the BMJ Publishing Group Limited. For permission to use (where not already granted under a licence) please go to http://group.bmj.com/group/rights-licensing/permissions
Other content recommended for you
- Ring-enhancing spinal cord lesions in neuromyelitis optica spectrum disorders
- A practical approach to the diagnosis of spinal cord lesions
- Neuromyelitis optica: an overview
- Attack-related damage of thalamic nuclei in neuromyelitis optica spectrum disorders
- Current concept of neuromyelitis optica (NMO) and NMO spectrum disorders
- Is it an inflammatory myelopathy?
- Neuromyelitis optica spectrum disorder and adenocarcinoma of ovary: a novel association
- Diagnostic value of intereye difference metrics for optic neuritis in aquaporin-4 antibody seropositive neuromyelitis optica spectrum disorders
- Neuromyelitis optica spectrum disorder (NMOSD) presenting as acute transverse myelitis with positive aquaporin 4 antibodies
- Astrocytic outer retinal layer thinning is not a feature in AQP4-IgG seropositive neuromyelitis optica spectrum disorders